Jill Andersen - 01 Nov 2021 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Legal Officer, Secretary
Signature
/s/ Dorothy Vinsky, Attorney-in-Fact
Issuer symbol
IVVD
Transactions as of
01 Nov 2021
Transactions value $
$0
Form type
4
Filing time
02 Nov 2021, 18:02:02 UTC
Next filing
01 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +514,863 $0 514,863 01 Nov 2021 Common Stock 514,863 $30.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter (1/4) of the option shall vest on November 1, 2022, and thereafter, the remainder of the option shall vest in 36 equal monthly installments on the 1st day of each month, subject to the Reporting Person's continuous service on each vesting date.